×
About 101,430 results

ALLMedicine™ Hepatitis C Center

Research & Reviews  48,653 results

Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respond...
https://doi.org/10.1186/s12889-020-09549-w
BMC Public Health; Prouté M, Le Coeur S et. al.

Sep 25th, 2020 - People who inject drugs (PWID) are the most exposed to hepatitis C virus (HCV). In Thailand, drug use is highly criminalized, and harm reduction services are scarce. This study estimates risky injection practices and assesses the proportion of HCV...

Beyond clinical outcomes: the social and healthcare system implications of hepatitis C ...
https://doi.org/10.1186/s12879-020-05426-4
BMC Infectious Diseases; Torrens M, Soyemi T et. al.

Sep 25th, 2020 - Hepatitis C virus (HCV) infections in people who inject drugs (PWID) can now be treated and cured. However, the impact that HCV treatment has on drug-user health, practices and wellbeing is not known. The aim of this research was to understand the...

Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During...
https://doi.org/10.1007/s10620-020-06616-5
Digestive Diseases and Sciences; Patel YA, Yao J et. al.

Sep 24th, 2020 - Patients with chronic hepatitis C and risky/harmful alcohol use experience poor outcomes. Granular data evaluating whether alcohol counseling during hepatitis C treatment impacts longitudinal alcohol consumption are lacking. To evaluate whether pr...

Review on the molecular epidemiology of sexually acquired hepatitis C virus infection i...
https://doi.org/10.1002/jia2.25618
Journal of the International AIDS Society REFERENCES; Chan CP, Uemura H et. al.

Sep 24th, 2020 - Sexual acquisition has emerged as a transmission route for hepatitis C virus (HCV) of growing importance among human immunodeficiency virus (HIV)-positive populations. In Western countries, HCV epidemics have been increasingly detected among men w...

Comparison of antiplatelet antibody profiles between hepatitis C virus-associated immun...
https://doi.org/10.1080/09537104.2020.1820975
Platelets Huang CE, Chen WM et. al.

Sep 24th, 2020 - Hepatitis C virus-associated immune thrombocytopenia (HCV-ITP) has been assumed to be one of secondary ITP and associated with antiplatelet antibodies. This study was to clarify the antibody profile in HCV-ITP compared with primary ITP. We enrolle...

see more →

Guidelines  143 results

EASL recommendations on treatment of hepatitis C - Final update of the series.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology;

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Opioid Use Disorder: Medical Treatment Options
https://www.aafp.org/afp/2019/1001/p416.html
American Family Physician; Coffa,D.,et al

Sep 30th, 2019 - Opioid use disorder is highly prevalent and can be fatal. At least 2.1 million Americans 12 years and older had opioid use disorder in 2016, and approximately 47,000 Americans died from opioid overdoses in 2017. Opioid use disorder is a chronic re...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 23rd, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

Alarming number of heart infections tied to opioid epidemic
https://newsroom.heart.org/news/alarming-number-of-heart-infections-tied-to-opioid-epidemic

Sep 17th, 2019 - An alarming number of people nationwide are developing infections of either the heart’s inner lining or valves, known as infective endocarditis, in large part, due to the current opioid epidemic. This new trend predominantly affects young, white, ...

see more →

Drugs  87 results see all →

Clinicaltrials.gov  49,989 results

Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respond...
https://doi.org/10.1186/s12889-020-09549-w
BMC Public Health; Prouté M, Le Coeur S et. al.

Sep 25th, 2020 - People who inject drugs (PWID) are the most exposed to hepatitis C virus (HCV). In Thailand, drug use is highly criminalized, and harm reduction services are scarce. This study estimates risky injection practices and assesses the proportion of HCV...

Beyond clinical outcomes: the social and healthcare system implications of hepatitis C ...
https://doi.org/10.1186/s12879-020-05426-4
BMC Infectious Diseases; Torrens M, Soyemi T et. al.

Sep 25th, 2020 - Hepatitis C virus (HCV) infections in people who inject drugs (PWID) can now be treated and cured. However, the impact that HCV treatment has on drug-user health, practices and wellbeing is not known. The aim of this research was to understand the...

Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During...
https://doi.org/10.1007/s10620-020-06616-5
Digestive Diseases and Sciences; Patel YA, Yao J et. al.

Sep 24th, 2020 - Patients with chronic hepatitis C and risky/harmful alcohol use experience poor outcomes. Granular data evaluating whether alcohol counseling during hepatitis C treatment impacts longitudinal alcohol consumption are lacking. To evaluate whether pr...

Review on the molecular epidemiology of sexually acquired hepatitis C virus infection i...
https://doi.org/10.1002/jia2.25618
Journal of the International AIDS Society REFERENCES; Chan CP, Uemura H et. al.

Sep 24th, 2020 - Sexual acquisition has emerged as a transmission route for hepatitis C virus (HCV) of growing importance among human immunodeficiency virus (HIV)-positive populations. In Western countries, HCV epidemics have been increasingly detected among men w...

Comparison of antiplatelet antibody profiles between hepatitis C virus-associated immun...
https://doi.org/10.1080/09537104.2020.1820975
Platelets Huang CE, Chen WM et. al.

Sep 24th, 2020 - Hepatitis C virus-associated immune thrombocytopenia (HCV-ITP) has been assumed to be one of secondary ITP and associated with antiplatelet antibodies. This study was to clarify the antibody profile in HCV-ITP compared with primary ITP. We enrolle...

see more →

News  2,477 results

Will Gilead price its coronavirus drug for public good or company profit?
https://www.reuters.com/article/us-health-coronavirus-gilead-pricing/will-gilead-price-its-coronavirus-drug-for-public-good-or-company-profit-idUSKBN22I2NM

May 6th, 2020 - (Reuters) - Gilead Sciences Inc (GILD.O) faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus. FILE PHOTO: An ampule of Ebola drug Remdesivir is pictur...

HCV screening risk factors in pregnant women need updating
https://www.mdedge.com/obgyn/article/219677/obstetrics/hcv-screening-risk-factors-pregnant-women-need-updating?channel=27970
Heidi Splete

Mar 27th, 2020 - Current risk factors used to screen for hepatitis C should be updated, according to study results of 106,842 pregnant women who underwent screening. Courtesy NIH “Because risk-factor screening has obvious limitations, universal screening in pregna.

Stick with the full 12-week DAA course for acute HCV
https://www.mdedge.com/gihepnews/article/219071/hepatitis/stick-full-12-week-daa-course-acute-hcv?channel=346
M. Alexander Otto, MDedge News

Mar 16th, 2020 - The first randomized trial to see if a short course of a direct-acting antiviral works as well for acute hepatitis C virus (HCV) infection as the standard 12-week course was stopped early after it became clear that it did not, according to a repor.

Experts recommend testing U.S. adults ages 18-79 for hep C
https://www.reuters.com/article/us-health-hepatitisc-screening/experts-recommend-testing-u-s-adults-ages-18-79-for-hep-c-idUSKBN20P2HS

Mar 2nd, 2020 - (Reuters Health) - With improved effectiveness of hepatitis C treatments, it’s worthwhile to screen U.S. adults for the virus, an expert panel says. The recommendations from the U.S. Preventive Services Task Force (USPSTF), published in JAMA, come...

Screen all adults for hepatitis C, says USPSTF
https://www.mdedge.com/jcomjournal/article/218184/infectious-diseases/screen-all-adults-hepatitis-c-says-uspstf?channel=39313
Heidi Splete

Mar 2nd, 2020 - Adults aged 18-79 years should be screened for hepatitis C virus infection, according to an updated grade B recommendation from the U. S.

see more →

Patient Education  81 results see all →